Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2020
Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiencyLena J McLaughlin, Lora Stojanovic, Aksinija A Kogan, et al.Pharmaceuticals (Basel, Switzerland)|January 23, 2016
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2Rena G Lapidus, Brandon A Carter-Cooper, Mariola Sadowska, et al.Scientific Reports|December 4, 2020
SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphomaKavita Bhalla, Sausan Jaber, Kayla Reagan, et al.Blood|October 22, 2024
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemiaYuchen Liu, Dominique R Bollino, Osman M Bah, et al.Cancer Cell|October 12, 2016
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for CancerNidal E Muvarak, Khadiza Chowdhury, Limin Xia, et al.Cancer|December 9, 2022
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Muthukumar Gunasekaran, et al.Leukemia|November 17, 2020
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemiaAshkan Emadi, Bandish Kapadia, Dominique Bollino, et al.Cancer Chemotherapy and Pharmacology|November 10, 2017
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Jennie Y Law, Erin T Strovel, et al.Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.Nature Communications|December 22, 2025
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement riskYimeng Wang, Andrey Galkin, Xiaoran Shang, et al.Pageof 12